Trademark: 90370409
Word
TYVASO DPI (TREPROSTINIL) INHALATION POWDER
Status Date
Tuesday, June 14, 2022
Registration Number
6756715
Registration Date
Tuesday, June 14, 2022
Filing Date
Wednesday, December 9, 2020
Published for Opposition
Tuesday, March 29, 2022
5 Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis, where the pharmaceutical preparations contain prostaglandins
The mark consists of the words "TYVASO/DPI" above the wording "(treprostinil) INHALATION POWDER" with two arcs to the right of the wording.
"DPI TREPROSTINIL INHALATION POWDER"
Jun 14, 2022
Notice Of Registration Confirmation Emailed
Jun 14, 2022
Registered-Principal Register
Mar 29, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 29, 2022
Published For Opposition
Mar 9, 2022
Notification Of Notice Of Publication E-Mailed
Feb 18, 2022
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Feb 17, 2022
Approved For Pub - Principal Register
Feb 17, 2022
Use Amendment Accepted
Feb 16, 2022
Examiner's Amendment Entered
Feb 16, 2022
Assigned To Lie
Feb 15, 2022
Notification Of Examiners Amendment E-Mailed
Feb 15, 2022
Examiners Amendment E-Mailed
Feb 15, 2022
Examiners Amendment -Written
Nov 30, 2021
Amendment To Use Processing Complete
Nov 30, 2021
Use Amendment Filed
Nov 29, 2021
Teas Amendment Of Use Received
Nov 18, 2021
Teas/Email Correspondence Entered
Nov 18, 2021
Correspondence Received In Law Office
Nov 18, 2021
Teas Response To Office Action Received
Jun 10, 2021
Notification Of Non-Final Action E-Mailed
Jun 10, 2021
Non-Final Action E-Mailed
Jun 10, 2021
Non-Final Action Written
May 28, 2021
Assigned To Examiner
Feb 17, 2021
Notice Of Design Search Code E-Mailed
Feb 16, 2021
New Application Office Supplied Data Entered In Tram
Dec 12, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
